BPC-157, or Body Protecting Compound-157, is a 15-amino-acid peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) isolated from gastric juices.[1][2] It was first identified in the 1990s as part of research into cytoprotective agents that safeguard the gastrointestinal (GI) tract from damage.[3] Unlike many peptides, BPC-157 is highly stable in acidic environments, allowing for oral administration without significant degradation.[4] In compounding pharmacies, BPC-157 is often prepared as capsules, injectables, or topical formulations
In clinical studies, Tirzepatide has helped patients lose a significant percentage of their body weightoften 1522% or moremaking it one of the most effective medical weight loss solutions available today
PlexusDx maps 14 distinct metabolic pathways and 49 peptides involved in weight regulation, generating personalized insights that guide protocol selection
The popular diabetes and weight loss medication semaglutide, known by brand names Ozempic and Wegovy, might offer hope for those struggling to quit smoking
The World Anti-Doping Agency lists MT-II under Section S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics) as a melanocortin agonist banned at all times on the WADA Prohibited List [17]
D.ZornB